Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Perspective Therapeutics (CATX) Net Income towards Common Stockholders (2016 - 2026)

Perspective Therapeutics' Net Income towards Common Stockholders history spans 17 years, with the latest figure at -$26.2 million for Q1 2026.

  • On a quarterly basis, Net Income towards Common Stockholders changed N/A to -$26.2 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$25.7 million, a 5139.8% decrease, with the full-year FY2025 number at $514000.0, up 154.16% from a year prior.
  • Net Income towards Common Stockholders hit -$26.2 million in Q1 2026 for Perspective Therapeutics, down from $514000.0 in the prior quarter.
  • Over the last five years, Net Income towards Common Stockholders for CATX hit a ceiling of $514000.0 in Q2 2025 and a floor of -$26.2 million in Q1 2026.
  • Historically, Net Income towards Common Stockholders has averaged -$3.8 million across 5 years, with a median of -$1.5 million in 2023.
  • Biggest five-year swings in Net Income towards Common Stockholders: plummeted 127.82% in 2023 and later skyrocketed 204.9% in 2025.
  • Tracing CATX's Net Income towards Common Stockholders over 5 years: stood at -$2.3 million in 2022, then plummeted by 127.82% to -$5.2 million in 2023, then surged by 90.55% to -$490000.0 in 2024, then skyrocketed by 204.9% to $514000.0 in 2025, then plummeted by 5195.14% to -$26.2 million in 2026.
  • Business Quant data shows Net Income towards Common Stockholders for CATX at -$26.2 million in Q1 2026, $514000.0 in Q2 2025, and -$490000.0 in Q2 2024.